![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
To date, sociology of health and medicine has engaged in only a limited way in debates about cognitive enhancement drugs and how they might affect or change the way we live our lives. In this review we explore the implications of the development of such drugs, both now and in the future, with particular reference to the changing drivers and dynamics of medicalisation or biomedicalisation over time. Whilst both concepts shed important light on these developments, pharmaceuticalisation provides a more precise sociological term of reference we suggest for tracing and tracking these trends in cognitive enhancing drugs over time. The paper ends with some further suggestions for a research agenda in this domain, drawing on concepts located at the nexus between science and technology studies (STS) and the sociology of health and biomedicine.
